Speakers

Bas Baaten, PhD
Pfizer

Renier Brentjens, MD, PhD
Roswell Park Comprehensive Cancer Center

Jia Fan, MD, PhD
Zhongshan Hospital, Fudan University

Qiang Gao, MD, PhD
Zhongshan Hospital, Fudan University

Michelle Krogsgaard, PhD
NYU Grossman School of Medicine

Yufeng (Jeff) Li
CorDx

Taha Merghoub, PhD
Weill Cornell Medicine

Robert Samstein, MD, PhD
Icahn School of Medicine at Mount Sinai

David Scheinberg , MD, PhD
Memorial Sloan Kettering Cancer Center

Mei Tian, MD, PhD
Human Phenome Institute, Fudan University

Hongxia Wang, PhD
Fudan University Shanghai Cancer Center

Jiong Wu, MD, PhD
Fudan University Shanghai Cancer Center

Huaqiang Eric Xu, PhD
Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Zi-Xun Yan, MD, PhD
Ruijin Hospital of Shanghai Jiao Tong University School of Medicine

Minhua Zheng, MD, PhD
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Caicun Zhou, MD, PhD
Shanghai East Hospital, Cancer Institute of Tongji University School of Medicine

James Allison, PhD
The University of Texas MD Anderson Cancer Center

Melanie Brickman Borchard, PhD, MSc
The New York Academy of Sciences

Nicholas B. Dirks, PhD
The New York Academy of Sciences

Sheng Xu, PhD
Stanford University

Jie Zhang, PhD
Shanghai Association for Science and Technology

Melanie Brickman Borchard, PhD, MSc
The New York Academy of Sciences

Liang Dong, PhD
The New York Academy of Sciences

Ming Ni, MPH
Fudan University Shanghai Cancer Center; Shanghai Anti-Cancer Association

Megan Prescott, PhD
The New York Academy of Sciences

Shi Xiao
The Shanghai Association for Science and Technology

Sheng Xu, PhD
Stanford University

Stanford University
Sheng Xu, PhD

Northwest Biotherapeutics, Inc.
George Zavoico

Memorial Sloan Kettering Cancer Center
Andy Minn, MD, PhD